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Abstract
Mice lacking the axon guidance molecule EphA4 have been shown to exhibit extensive axonal regeneration and functional
recovery following spinal cord injury. To assess mechanisms by which EphA4 may modify the response to neural injury a
microarray was performed on spinal cord tissue from mice with spinal cord injury and sham injured controls. RNA was
purified from spinal cords of adult EphA4 knockout and wild-type mice four days following lumbar spinal cord hemisection
or laminectomy only and was hybridised to Affymetrix All-Exon Array 1.0 GeneChips
TM. While subsequent analyses indicated
that several pathways were altered in EphA4 knockout mice, of particular interest was the attenuated expression of a
number of inflammatory genes, including Arginase 1, expression of which was lower in injured EphA4 knockout compared
to wild-type mice. Immunohistological analyses of different cellular components of the immune response were then
performed in injured EphA4 knockout and wildtype spinal cords. While numbers of infiltrating CD3+ T cells were low in the
hemisection model, a robust CD11b+ macrophage/microglial response was observed post-injury. There was no difference in
the overall number or spread of macrophages/activated microglia in injured EphA4 knockout compared to wild-type spinal
cords at 2, 4 or 14 days post-injury, however a lower proportion of Arginase-1 immunoreactive macrophages/activated
microglia was observed in EphA4 knockout spinal cords at 4 days post-injury. Subtle alterations in the neuroinflammatory
response in injured EphA4 knockout spinal cords may contribute to the regeneration and recovery observed in these mice
following injury.
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Introduction
The Eph receptors are the largest family of tyrosine kinases [1,2]
and together with their ligands, the ephrins, they play a major role
in modulation of numerous biological functions. They are
expressed in a wide variety of tissues during development and in
the adult, including in the central nervous system (CNS). Eph-
ephrin signalling affects numerous processes in the developing
CNS, largely related to cell adhesion/repulsion and cytoskeletal
changes, including acting as axon guidance cues in the developing
CNS, steering growth cones to their correct locations. EphA4
expression is vital for the correct establishment of spinal cord
circuitry as demonstrated by the phenotype of EphA4 knockout
mice [3] and is expressed within the developing spinal cord, where
it has a critical role in the guidance of corticospinal tract axons [4].
Within the adult rodent spinal cord, EphA4 protein has been
localised to axons of the dorsal funiculus [5], substantia gelatinosa
[5], and glial cells within the white matter [5]. Weak expression
has been observed in some motor neurons [6] and grey matter
astrocytes [7]. EphA4 expression is markedly upregulated in the
adult spinal cord following injury. EphA4 knockout mice display
significant axonal regrowth by six weeks post-spinal cord injury
(SCI), while histological differences between injured EphA4
knockout and wild-type mice are already evident as early as
4 days post-injury [6]. Further, in wild-type mice, blocking of the
EphA4 receptor promotes axonal regeneration and functional
recovery following SCI [8].
Ephs and ephrins are also associated with immune function and
inflammation [9]. Expression of Ephs and ephrins can be
upregulated by pro-inflammatory mediators in cell lines in vitro,
and the changing expression of Ephs and ephrins may play a role
in leukocyte movement into sites of inflammation by affecting the
adhesion of leukocytes, and altering vascular permeability by
changing the adhesion of endothelial cells [10] and CNS vascular
formation [11]. Numerous Ephs and ephrins are expressed in
endothelial cells, as well as leukocytes including monocytes and
lymphocytes [10] and Eph receptor activation can regulate T
lymphocyte adhesion [12]. EphA4 expression has been detected in
subpopulations of CD4+ [13,14] and CD8+ T lymphocytes [14],
B lymphocytes [15,16] and platelets [17,18]. In the CNS,
inflammatory cells in lesions from multiple sclerosis patients were
found to express EphA4, as well as a number of other Ephs and
ephrins [19].
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FA significant non-CNS phenotype observed in EphA4 knockout
mice relates to their immune system. The thymic epithelium does
not develop normally in these mice; by 4 weeks of age, the thymus
of knockout mice is significantly smaller (with respect to body size)
than seen in their wild-type littermates, leading to altered T cell
development [20]. Therefore, while EphA4 knockout mice are in
general healthy and their most obvious phenotype is a hopping
gait, numerous physiological processes are subtly altered in these
mice – not only in the CNS, but also in the vascular and immune
systems.
EphA4 upregulation has been localised to reactive astrocytes
following SCI in mice [6] and rats [7] and following brain injury in
the marmoset [21] and rat [22], as well as regulating astrocyte
reactivity in vitro [22,23]. Low levels of EphA4 protein have been
localised to axons near the lesion site in injured mice [6] and a
similar observation has been made in injured rats: while EphA4
mRNA levels did not change in neurons of the motor cortex
following injury, over time EphA4 protein accumulated in the
injured axon stumps adjacent to the spinal cord lesion [7].
Following SCI in rats, EphA4 has additionally been detected in
motor neurons [24].
There are a number of altered mechanisms which potentially
contribute to the axonal regeneration and functional recovery seen
in EphA4 knockout mice. The rationale behind performing the
original hemisection experiments described above [6] was that the
removal of a repulsive guidance cue from the lesion environment
would result in less inhibition of axons attempting regrowth.
However, many factors contribute to secondary damage and lack
of regeneration following CNS injury and the extensive regener-
ation in EphA4 knockout mice suggested other factors may be
contributing to this beneficial outcome, in addition to the removal
of a source of axonal repulsion. These additional factors may
include decreased astrocytic gliosis, altered blood flow or other
vascular alterations, and a differential inflammatory response.
As a constitutive knockout mouse, the absence of EphA4 during
development may lead to compensatory alterations in the
expression of other genes, which may also impact injury response.
Furthermore, EphA4 is expressed in multiple tissues, both within
and outside the CNS. While EphA4 is an important axon
guidance molecule and is upregulated in astrocytes following
injury, less is known about its expression in other CNS and
peripheral cell types relevant to SCI such as endothelial and
immune cells. Gene expression profiling, using microarrays or
other high-throughput technologies, is a powerful discovery tool
for identifying differences in biological processes between tissues
and has been widely used in neurosciences, particularly in models
of CNS injury. In this study we used genome wide expression
profiling to compare differential gene expression in wild-type and
EphA4 knockout mice following SCI, to identify mechanisms
regulated by EphA4 through which functional recovery may be
regulated.
Methods
Mice
All animal work was approved by the University of Melbourne
Anatomy & Cell Biology, Neuroscience, Pathology, Pharmacolo-
gy, and Physiology Animal Ethics Committee in accordance with
the Australian Code of Practice for the Care and Use of Animals
for Scientific Purposes, approval number 0703762. Male and
female EphA4 knockout mice and their wild-type littermates were
bred on a C57/Bl6 background and were aged between 10 and 14
weeks. The generation of EphA4 knockout mice is described in
Dottori et al [3]. Mice were group housed in standard cages with
free access to food and water and were kept on a 12 hour light/
dark cycle.
Spinal Cord Injury Surgery and Mouse Care
Mice were anaesthetised with an intraperitoneal (IP) injection
of ketamine (100 mg/g body weight; Ketamil, Troy Laborato-
ries, Aust.) and xylazine (13.5 mg/g body weight; Xylazil, Troy
Laboratories) in sterile phosphate buffered saline (PBS). Exper-
imental mice were given a lumbar spinal cord hemisection: two
to three vertebral laminae at T13-L1 were removed and the left
side of the spinal cord was sectioned manually with a fine
microsurgical knife (Coherent Scientific, Aust.). The spinal cord
was cut twice in the same place to ensure complete section.
Control mice underwent a laminectomy only. After surgery the
wound was closed with small metal clips (Becton Dickinson,
USA) applied using a skin applicator (World Precision
Instruments, USA).
Analgesia was provided by IP injection of Carprofen (5 mg/g
body weight; Rimadyl, Pfizer, UK) immediately following
anaesthesia and 24 hours post-surgery, subcutaneous application
of Lignocaine (Troy Laboratories) at the time of surgery, and
the addition of paracetamol to drinking water (2 mg/ml water;
liquid Panadol, GlaxoSmithKline, Aust.) for the remainder of
the experiment. 0.9% saline (NaCl in sterile H2O) equivalent to
2% of body weight was administered IP before surgery, two
hours post-surgery, and later as recommended by animal house
staff. Mice were culled if they displayed weakness in their right
leg, rapid weight loss, or any signs of lethargy or distress. All
efforts were made to minimise animal numbers and animal
discomfort.
RNA Extraction and Microarray Hybridisation
Twelve mice were used for the microarray experiment: EphA4
and wild-type mice were given a spinal cord hemisection (n=3 per
genotype), or laminectomy only (n=3 per genotype). Each
genotype group was gender-balanced with two males and one
female in each group. At 4 days post-injury mice were culled via
CO2 asphyxiation. After laminectomy, 6 millimetres of tissue
centred on the injury epicenter or equivalent area in control mice
was manually dissected from the left (injured) half of the spinal
cord. Tissue was immediately snap frozen on a mixture of
isopentane (Chem-Supply, Aust.) and dry ice and stored at
280uC. RNA was extracted by homogenising each sample in 1 ml
of TRIzol Reagent (Invitrogen, Aust.) according to the manufac-
turer’s protocol. Chloroform (Chem-Supply) was used in the phase
separation, and 2-propanol (Sigma-Aldrich) in RNA precipitation.
RNA was washed in 75% ethanol (from Molecular Biology Grade
absolute ethanol, Sigma-Aldrich) and the RNA pellet was air dried
briefly before being resuspended in RNase-free H2O. RNA was
further purified using the RNeasy Micro Kit (Qiagen, Aust.)
according to the manufacturer’s protocol and stored at 280uC.
Samples were processed by the Australian Genome Research
Facility (www.AGRF.org.au) where quality was assessed on an
Agilent Bioanalyser 2100 before 1 mg RNA was hybridised to
Affymetrix Mouse All-Exon ST Array GeneChips
TM, with RNA
from a single mouse spinal cord hybridised to an individual
GeneChip
TM.
Bioinformatic Analysis
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus [25] and are accessible
through GEO Series accession number GSE34430 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34430).
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(Partek, Missouri, USA) to assess the quality of the data and
perform statistical analyses. Affymetrix CEL files were imported
using the Robust Multi-Chip Average (RMA) algorithm. Affyme-
trix library files used in conjunction with Partek Genomics Suite
were the V1 release version for the Mouse Exon 1.0 ST Array,
and annotation files were from NetAffx (www.affymetrix.com).
Core probesets only were selected and a gene-level summary
analysis was conducted. Only relevant CEL files were loaded into
Partek for analyses using only sham-operated or only injured
samples; all files were loaded to conduct analyses of all samples,
and all samples were normalised before conducting hierarchical
clustering analysis. Few genes passed the stringent threshold for
False Discovery Rate; therefore a p-value cut-off of 0.01 and a
fold-change cut-off of 1.2 were used for all analyses to minimise
the risk of generating false positive results.
Several programs were used to further analyse the lists of
differentially expressed genes generated with the significance
level and fold-change settings above, and place them in a
functional context. Differentially expressed gene lists were
entered into GoMiner [26] (discover.nci.nih.gov/gominer), a
bioinformatics enrichment tool which uses data in the Gene
Ontology database (www.geneontology.org) to identify gene
ontology groups which are significantly over-represented in
gene lists. Gene ontology categories were allocated a p-value,
and we selected a p-value cut-off of 0.05. (The GoMiner
settings used were:organism=mouse; data sources=all; evidence
code=3.) Significant gene ontology groups containing only one
differentially expressed gene were disregarded to reduce the
likelihood of false positives. Approximately 10% of entered
genes were not recognised by GoMiner.
Histology
Post-injury timepoints included were 2, 4, 14 and 42 days. To
minimise animal number and suffering, naı ¨ve controls were used
to compare to the multiple post-injury timepoints. Mice were
culled with a lethal injection of pentobarbitone sodium
(Lethabarb, Virbac, Aust., 150 mg) and transcardially perfused
with 0.1 M phosphate-buffered saline (PBS) and 4% paraformal-
dehyde (PFA, Sigma-Aldrich, Aust.) in PBS. Spinal cord tissue
was post-fixed in 4% PFA for two hours, rinsed in PBS, and
placed in increasingly concentrated sucrose solutions (10%, 20%
and 30%) in PBS. Spinal cords were left in 30% sucrose
overnight, then immersed in Tissue-Tek O.C.T. compound
(Sakura Finetek, USA) and snap-frozen in isopentane (Ajax
Finechem, Aust.) cooled in liquid nitrogen. Spinal cords were
sectioned at 10 mm on a Leica cryostat onto Superfrost Plus
slides (Lomb Scientific, Aust.) in either the transverse or
horizontal plane, and stored at 280uC until used. Every tenth
slide from each spinal cord was stained with haematoxylin and
eosin to identify the lesion site and assess tissue morphology. The
rostro-caudal mid-point of lesioned tissue was deemed the injury
epicenter for subsequent analyses.
Immunohistochemistry
Cryosections were thawed at room temperature for at least
1 hour, rinsed in PBS, and incubated for a minimum of 30
minutes in blocking solution. For the majority of experiments, the
blocking solution used was PBS containing 2% normal goat serum
(NGS, Invitrogen, Aust.), 2% foetal calf serum (FCS, Thermo
Scientific, Aust.) and 0.2% Tween-20 (Ajax Finechem). For
Arginase 1 labelling, the blocking solution used was PBS
containing 2% bovine serum albumin (BSA, Sigma-Aldrich) and
0.2% Tween-20. Sections were incubated with primary antibody
diluted in blocking solution overnight at room temperature; these
included rat anti-CD11b (Millipore, 1:500), goat anti-Arginase 1
(Santa Cruz, 1:250), and rabbit anti-CD3 (Abcam, 1:500). Sections
were rinsed in PBS three times for a minimum of 5 minutes, then
incubated with a fluorophore-tagged secondary antibody diluted
in PBS for 1 hour at room temperature. Secondary antibodies
included goat anti-rat Alexa Fluor 488 (Invitrogen, 1:500), donkey
anti-goat Cy3 (Jackson ImmunoResearch, 1:500) and donkey anti-
rabbit Alexa Fluor 594 (Invitrogen, 1:500). For Arginase 1 and
CD11b double-labelling, sections were incubated with the
secondary antibody for Arginase 1 before being incubated with
the secondary antibody for CD11b, to avoid cross-reactivity. Cell
nuclei were counterstained with DAPI (Sigma-Aldrich). Secondary
antibody specificity was determined by omitting the primary
antibody.
Histological Analysis
Analysis of CD11b+ area in horizontal sections. CD11b
immunostaining for macrophages and activated microglia was
quantitated in a 1 mm rostro-caudal area encompassing the injury
(500 mm rostral and caudal to the injury epicentre). Between 3 and
6 horizontal cryosections spaced 100 mm apart were analysed from
uninjured (naı ¨ve) mice (n=3 wild-type, n=2 knockout) and
hemisectioned mice at 2 days (n=3 per genotype), 4 days (n=3
per genotype) and 14 days (n=2 per genotype) post-injury. The
horizontal sections used were close to the midline and displayed
both grey and white matter in intact areas. Images were taken on
an Olympus IX81 microscope at x10 magnification with minimal
alteration of imaging parameters between sections. The images
were coded for blinded analysis, and the area of CD11b staining as
a proportion of total tissue area on the injured side of the spinal
cord was determined using the thresholding function in ImageJ
(Rasband, W.S., ImageJ, U.S. National Institutes of Health,
Bethesda, Maryland, USA, http://imagej.nih.gov/ij, 1997–2011).
Additionally, the area of CD11b immunoreactivity was calculated
in the following rostral and caudal fields from the epicentre within
each section: 0 to 100 mm, 100 to 200 mm, 200 to 300 mm, 300 to
400 mm and 400 to 500 mm.
Analysis of CD11b+ area in transverse sections. CD11b
immunoreactivity was quantitated in a 200 mm area centred
around the lesion; 3 transverse cryosections spaced 100 mm apart
were used with the middle section through the injury epicentre.
Tissue was analysed from hemisectioned mice at 2 days (n=3 per
genotype), 4 days (n=6 per genotype) and 14 days (n=3 per
genotype) post-injury. Tiled images taken on a confocal micro-
scope at x40 magnification were compiled, coded for blinded
analysis, and the area of positive staining as a proportion of total
tissue area on the left hand side of the spinal cord was determined
using the thresholding function in Image.
CD11b density counts. The density of CD11b+ cells was
analysed in transverse sections within 200 mm of the injury
epicentre (as above). Images were taken on a confocal microscope
at x40 magnification and coded for blinded analysis. Cells were
counted in areas throughout the injured region and the density of
cells converted to cells/100 mm
2. 3 fields were counted in tissue
from hemisectioned mice at 2 days (n=3 per genotype) and
14 days (n=3 per genotype) post-injury and 8 fields from mice at
4 days post-injury (n=6 per genotype). CD11b+ cells were
counted when they co-localised with the DAPI nuclear counter-
stain.
Arginase 1-positive macrophage/activated microglia
counts. The proportion of Arginase 1 immunoreactive ces
which co-localised with CD11b+ macrophages/activated microg-
lia was counted in transverse sections within lesioned tissue. Tissue
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genotype), 4 days (n=6 per genotype) and 14 days (n=3 per
genotype) post-injury. Tiled images taken of the entire injured left
hand side of the spinal cord were taken on a confocal microscope
at x40 magnification, and coded for blinded analysis. A minimum
of 12 fields were counted from 2 days post-injury samples due to
low density of activated microglia/macrophages, and a minimum
of 8 fields were counted from 14 days post-injury samples. In 4
days post-injury samples, a minimum of 4 fields were selected from
each of the ‘inner’ areas, closer to the midline of the spinal cord
where macrophages were densely packed, as well as the ‘edge’
areas, where macrophages were dispersed among areas of necrotic
tissue. CD11b+ cells with a DAPI nuclear counterstain were
counted as either Arginase 1-positive or Arginase 1-negative.
Statistics
For histological analyses, statistics were generated using
Student’s t-test in GraphPad Prism (version 4.03, GraphPad
Software, Inc.) and values are represented as mean 6 standard
error of the mean (SEM). Results were considered statistically
significant at p,0.05.
Results
Quality Control of RNA and Microarray Samples
Assessment of RNA integrity on the Agilent Bioanalyser 2100
indicated an average RNA Integrity Number (RIN) of 9.5, thus
RNA samples provided for the microarray were of high quality
(Fig. S1A). The expression data was entered into Partek Genomics
Suite where quality control analyses were performed. Principal
Components Analysis (PCA) mapping indicated that the greatest
variation between spinal cord samples was due to treatment, i.e.
between sham-operated and injured samples (Fig. S1B). There was
no obvious clustering based on genotype, gender, or RNA
extraction date. No samples were identified as biological or
technical outliers, therefore all samples were included in the
subsequent bioinformatic analysis.
Differential gene expression in sham-operated EphA4
knockout and wild-type spinal cords
To identify underlying gene expression differences between
EphA4 knockout and wild-type spinal cords, a one-way Analysis of
Variance (ANOVA) of sham-operated samples only was conduct-
ed (with genotype as factor). 119 genes were differently expressed
between control EphA4 knockout and wild-type mice; 56 genes
had a decreased expression in EphA4 knockout compared to wild-
type spinal cords, while 63 had an increased expression.
Enrichment analysis using GoMiner was conducted to identify
altered biological processes, molecular functions or cellular
components involving more than one gene, to provide a more
robust and comprehensive exploration of the data. Twenty four
gene ontology categories were significantly over-represented in the
gene list when applying a p-value cut-off of 0.05 (Table 1). Gene
ontology categories were contained within 3 ontology domains:
Biological Process, Molecular Function and Cell Component. The
significant gene ontology categories containing the highest number
of differentially expressed genes were ‘intracellular organelle’ and
‘organelle’ (56 genes), ‘intracellular membrane-bounded organelle’
and ‘membrane-bounded organelle’ (50 genes), ‘nucleus’ (35
genes), ‘cellular macromolecule biosynthetic process’ and ‘macro-
molecule biosynthetic process’ (23 genes), ‘transcription’ (19 genes)
and ‘regulation of gene expression’ (19 genes).
Differential gene Expression in Injured EphA4 Knockout
and Wild-type Spinal Cords
To identify genes differentially expressed between genotypes
following CNS injury, a one-way ANOVA was performed
comparing injured groups only: 71 genes differentially expressed
between genotypes passed a cut-off of p,0.01 and a fold change of
$1.2 (Table S1). Arginase 1 narrowly missed this p-value threshold
(p=0.0164), however it was identified as a candidate gene for
further analysis due to having the largest fold change (fold change
3.11) in the dataset.
Expression profiles of the 71 differentially expressed genes were
then analysed across all four treatment groups using hierarchical
clustering on expression data from all samples (Fig. S2). This
identified groups of genes with similar expression profiles across all
treatment groups. There were four distinct clusters containing
genes with similar expression profiles, denoted clusters A to D
(Fig. 1). Cluster A includes genes with a relatively low level of
expression in sham-operated samples of both genotypes and
upregulated expression in both genotypes following SCI. However
the post-injury increase in gene expression was attenuated in
EphA4 knockout compared to wild-type samples. A number of
these genes are related to inflammation or immune function.
These include Fc receptor, IgG, high affinity I (Fcgr1), CASP8 and
FADD-like apoptosis regulator (Cflar), Cysteinyl leukotriene
receptor 1 (Cysltr1), Nuclear protein 1 (Nupr1), CD244 natural
killer cell receptor 2B4 (Cd244), Toll-like receptor 6 (Tlr6), MAP
kinase-activated protein kinase 2 (Mapkapk2), Caspase 1 (Casp1),
Src-like adaptor (Sla) and Cytotoxic T lymphocyte-associated
protein 2 alpha (Ctla2a). The expression profile of genes in cluster
A is shared by the gene Arginase 1 which is also related to
inflammation, being expressed in a subset of macrophages.
Arginase 1 was previously identified as a gene of biological
interest based on its relatively large expression difference between
injured wild-type and EphA4 knockout samples. The combination
of its large fold change, its association with inflammation, and the
similarity between its expression profile and that of other
differentially expressed genes related to inflammation and immune
function, led to the selection of Arginase 1 for further in vivo
analysis. This analysis was conducted alongside a comparison of
the general extent of inflammatory infiltration in injured wild-type
and EphA4 knockout spinal cords.
Validation of changes in gene expression was performed by use
of immunohistochemical localisation rather than RT-PCR. RT-
PCR validation requires the use of control genes. Ideally at least
three different control genes should be used, and they should be
expressed at about the same level of the target gene to be validated
and also not be differentially expressed in the biological system
being examined. For this project we investigated the use of a
number of standard control genes (Gapdh, Hprt1, Actb, B2
microglobulin, and Tbp). However all these genes were either
previously known to be differentially expressed in CNS tissue
following injury or were differentially expressed in our microarray
data and so no appropriate reference point could be reliably
established.
Histology of Wild-type and EphA4 Knockout Spinal Cords
Following Injury
To visualise the injury site and determine whether there was an
attenuation of the post-injury inflammatory response in EphA4
knockout mice compared to wild-type mice, the presence of
inflammatory cells (T cells and macrophages/activated microglia)
were primarily examined in vivo at 4 days post-injury, to parallel
the design of the microarray analysis and additionally at 2 and 14
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cords was examined using haematoxylin and eosin stained
cryosections and no gross histological differences between geno-
types were observed (Fig. S3).
T Cell Infiltration is Low in Both Wild-type and EphA4
Knockout Spinal Cords Following Hemisection
Previous studies using the contusion model of SCI have
identified peaks of T cell infiltration at approximately 2 and
6 weeks post-injury [27,28]. Using the pan T-lymphocyte marker
CD3, T cells were observed in the lesion sites of both genotypes as
early as 2 days post-injury and also at 4, 14 and 42 days post-
injury. (Fig. 2). CD3+ T cells were not observed in spared tissue or
intact spinal cords (data not shown). Very low numbers of CD3+ T
cells were observed in both horizontal and transverse sections at all
post-injury timepoints (approximately one CD3+ cell or less per
section), which prevented meaningful quantitation between
genotypes or timepoints. There was no indication of increased T
cell infiltration at 14 or 42 days post-injury.
Area, Rostro-caudal Spread and Density of Macrophages/
Activated Microglia in Injured Wild-type and EphA4
Knockout Spinal Cords
The distribution of infiltrating macrophages and activated
microglia in horizontal cryosections of injured wild-type and
EphA4 knockout spinal cords was visualised with CD11b
immunoreactivity at 2, 4 and 14 days post-injury and in uninjured
control mice. The spread of cells was analysed by measuring the
proportional area of CD11b immunoreactivity within 100 mm
rostro-caudal zones up to 500 mm from the epicentre, and also by
measuring the overall proportional area of CD11b+ immunore-
activity up to 500 mm from the injury epicentre in the rostral and
caudal directions (i.e. a 1 mm rostro-caudal area) (Fig. 3 A,B). The
average proportional area of CD11b+ staining in the 1 mm rostro-
caudal area encompassing the injury was not significantly different
between genotypes in uninjured spinal cords or between genotypes
at any post-injury timepoint examined (Fig. 3C). At all timepoints
and in both genotypes, some macrophages/activated microglia
were present beyond 500 mm from the epicentre but in relatively
low numbers.
The proportional area of CD11b+ staining within 100 mm
rostral-caudal zones from the epicentre was analysed in the same
sections. At each timepoint, there was a general trend for zones
closer to the injury epicentre to have a higher proportion of
tissue occupied by macrophages/activated microglia, and for the
proportion to decrease with distance from the epicentre
(Fig. 3F,I,L). At 2 days post-injury, rounded macrophages/
activated microglia sparsely populated the necrotic tissue
surrounding the hemisection in both genotypes (Fig. 3D,E,F).
The largest area of CD11b staining was seen at 4 days post-
injury, where there was also the greatest variation between
samples, particularly close to the lesion centre. A large number of
CD11b immunoreactive cells populated the injury site, compact-
ed in the lesion centre (Fig. 3G,H,I). At 14 days, large numbers
of CD11b+ macrophages/activated microglia continued to
populate the hemisection site (Fig. 3J,K,L). Rather than the
spherical shape observed at earlier post-injury timepoints, by 14
days post-injury a number of strongly CD11b immunoreactive
cells had a less rounded morphology and short processes. There
was no significant difference between genotypes in any individual
rostro-caudal zone from the epicentre at all timepoints examined.
This was confirmed by additional measurements in transverse
sections through the lesion epicentre and at 100 mm rostral and
caudal to the epicentre. (Fig. 4 A,B,D). CD11b+ cells within the
lesion epicentre were also counted at higher power in transverse
sections to confirm that the area of CD11b staining correlated
with numbers of macrophages/activated microglia (Fig. 4C).
There was no significant difference between genotypes in the
density of CD11b+ cells at any post-injury timepoint examined
(Fig. 4E).
Table 1. Comparison of sham-operated wild-type and EphA4 knockout spinal cords: gene ontology groups over-represented in
list of differentially expressed genes.
Biological Process p-value Molecular Function p-value
Regulation of pH 0.0058 Enzyme activator activity 0.0021
Monovalent inorganic cation GTPase activator activity 0.0201
Homeostasis 0.0089 GTPase regulator activity 0.0392
Mitochondrion organization 0.0145 Nucleoside-triphosphatase regulator
Regulation of transcription 0.0317 Activity 0.0419
Transcription 0.0346
Regulation of cell morphogenesis Cellular Component p-value
Involved in differentiation 0.0361 Nucleus 0.0083
Regulation of gene expression 0.0375 Intracellular organelle 0.0143
Cellular macromolecule biosynthetic Organelle 0.0145
Process 0.0408 Cell junction 0.0175
Macromolecule biosynthetic process 0.0420 Intracellular membrane-bounded
Positive regulation of apoptosis 0.0442 Organelle 0.0275
Positive regulation of programmed Membrane-bounded organelle 0.028
cell death 0.0456 Synapse 0.0362
Positive regulation of cell death 0.0463 Proteasome complex 0.0423
(GoMiner analysis: significance level of p,0.05).
doi:10.1371/journal.pone.0037635.t001
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Activated Microglia is Lower in EphA4 Knockout
Compared to Wild-type Spinal Cords at 4 Days Post-
injury
Arginase 1 is a marker of a macrophage subset, and Arginase
1 mRNA expression was three-fold lower in injured EphA4
knockout compared to wild-type spinal cords at 4 days post-injury.
In sham-operated and naı ¨ve control spinal cords, Arginase 1
immunoreactivity was observed at low levels in motor neurons of
the ventral horn. No Arginase 1 immunoreactivity was detected in
any other cells in uninjured spinal cords of either genotype.
Following injury, Arginase 1 immunoreactivity in surviving motor
neurons exhibited no detectable change (data not shown).
In contrast, a large number of Arginase 1 and CD11b co-
labelled cells were present in the lesion site of both genotypes
following injury (Fig. 5A). At 4 days post-injury, Arginase 1 was
strongly immunoreactive in many CD11b+ cells with a rounded
morphology but was not detected in ramified CD11b+ cells
(resting microglia). Qualitative analysis indicated that Arginase 1
positive macrophages/activated microglia were not randomly
distributed throughout the lesion site; Arginase 1 immunoreactiv-
ity appeared to be stronger and present in a greater proportion of
CD11b+ cells in areas of obvious necrosis or tissue loss, frequently
in cells which resembled ‘foamy macrophages’. These areas tended
to be on the periphery of the spinal cord in transverse sections, and
were termed ‘edge’ areas (box ii in Fig. 5A). Arginase 1
immunoreactivity qualitatively appeared to be weaker and in a
slightly lower proportion of CD11b+ cells which were densely
packed together in the lesion centre. These areas tended to be
located more centrally in the spinal cord in transverse sections, and
were termed ‘inner’ areas (box i in Fig. 5A).
There was a significantly lower proportion (p=0.0018, Fig. 5B)
of Arginase 1/CD11b co-labelled cells in ‘inner’ areas in EphA4
knockout (Fig. 5C-E) compared to wild-type spinal cords (Fig. 5F–
H) at 4 days post injury. In contrast, there was no significant
difference in the proportion of Arginase 1 and CD11b co-labelled
cells in ‘edge’ areas in EphA4 knockout and wild-type lesions
(Fig. 5I-N). There was also no difference at 2 or 14 days post-
injury between genotypes and no obvious difference in the
distribution of Arginase 1 positive cells within the lesion site
(Fig. 5B).
Discussion
EphA4 knockout mice display axonal regrowth and functional
recovery following spinal cord hemisection [6], however the
altered mechanisms underlying this regeneration have not been
Figure 1. Hierarchical clustering of differentially expressed genes generated by comparison of injured wild-type and EphA4
knockout samples. Hierarchical clustering identified subsets of differentially expressed genes with similar expression profiles across groups. A
cluster was chosen for further analysis (enlarged, cluster A); expression of genes in this cluster was relatively low in both sham-operated wild-type and
EphA4 knockout samples and increased after injury in both genotypes. However the upregulation in injured EphA4 knockout samples was
attenuated compared to injured wild-type samples. A number of genes with this expression profile were related to inflammation or immune function.
KO=knockout.
doi:10.1371/journal.pone.0037635.g001
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potentially contribute to this regeneration, gene expression
profiling was conducted on injured and uninjured spinal cord
tissue from EphA4 knockout and wild-type mice.
Transcriptional Differences in the Uninjured EphA4
Knockout Spinal Cord
Comparison of spinal cords from sham-operated EphA4
knockout and wild-type mice reveals inherently modest (generally
less than 2-fold) gene expression differences between the
genotypes. A large proportion of significantly differentially
expressed genes were related to the nucleus and the regulation
of transcription. With application of the p-value, fold change filter
and enrichment analysis described above, almost half of the
differentially expressed genes were related to ‘intracellular
organelle’ or similar categories, suggesting that fundamental
differences may exist within cells of EphA4 knockout mice.
However more work is required to determine whether, or how,
these differences affect cellular function following injury.
Inflammation-related genes are Differentially Expressed
in EphA4 Knockout Spinal Cords Following Injury
Differential expression of a number of immune and inflamma-
tion-related genes following injury is of particular interest, as the
post-traumatic neuroinflammatory response plays a role in both
repair and increased secondary injury in the CNS. A number of
inflammation-related genes were found to be differentially
expressed between genotypes following injury, including genes
related to the innate and adaptive immune responses. A group of
genes were identified by hierarchical clustering as being upregu-
lated after injury in both genotypes, but the increase was
attenuated in EphA4 knockout compared to wild-type samples.
These genes, including Tlr6, Casp1, Cflar, Mapkapk2, Nupr1, Fcgr1,
Ctla2a, Sla, Cd244 and Cysltr1, have diverse roles relating to the
immune system and inflammation. For example, Tlr6, Casp1 and
Cflar are involved in the regulation of the innate immune response:
Tlr6 has been detected in mouse and human microglia and the
TLR family is linked to microglial activation [29,30]. Additional
inflammation-related genes were identified in the list of genes that
were differentially expressed between injured EphA4 knockout
and wild-type samples including Arginase 1, the expression of
which was approximately 3-fold lower in injured EphA4 knockout
compared to wild-type samples. Arginase 1 is expressed in neurons
of the spinal cord [31] and in a subset of macrophages including
alternatively activated (M2) macrophages; the marked upregula-
tion observed in injured samples in our experiment is likely due to
an influx of Arginase 1 positive macrophages which are abundant
in the days following rodent SCI [32].
The majority of immune/inflammation-related genes had an
attenuated increase in expression in injured EphA4 knockout
compared to wild-type samples, although the genes have diverse
functions, reflected by few significant gene ontology groups related
to specific inflammatory categories. Given that there was no
apparent gross difference in the inflammatory response to spinal
cord injury in the EphA4 knockout mice it suggested that specific
components of the inflammatory response may be altered, as was
the case for Arginase 1 at the specific timepoint of 4 days post-
injury and even then only in a subset of macrophages.
T Cell Infiltration in the Spinal Cord Hemisection Model
Studies of contusion SCI in C57/Bl6 mice indicate two peaks of
T lymphocyte infiltration occur at approximately 2 and 6 weeks
post-injury [27,28], timepoints that were included in this study.
Figure 2. T cell infiltration is low in both wild-type and EphA4 knockout spinal cords following hemisection. Sections of hemisectioned
spinal cord were double-labelled with the pan T-lymphocyte marker CD3 (red) and CD11b (green) to identify infiltrating T cells within injured tissue.
Images include DAPI nuclear counterstain (blue). A low number of CD3+ T cells (indicated by arrowheads) sparsely populated the injury site in both
wild-type and EphA4 knockout spinal cords at 2 (A, E), 4 (B, F), 14 (C, G) and 42 (D, H) days post-injury (d.p.i.). Scale bars: A, C, E, G, H=50 mm; B, D,
F=20mm.
doi:10.1371/journal.pone.0037635.g002
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37635Figure 3. The rostro-caudal area and spread of macrophages/activated microglia does not differ between injured EphA4 knockout
and wild-type spinal cords. Horizontal sections of spinal cord were immunostained with CD11b to label infiltrating macrophages and activated
microglia. An example is shown in the low power image in A; the square surrounds the CD11b+ lesion on the left hand side of the spinal cord. CD11b
immunoreactivity was converted to a positive area of staining by thresholding, and the proportional area of staining was analysed in 100 mm zones
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injury in both genotypes, but still only very low numbers at 14 and
42 days. As there are differences between contusion and
hemisection models of SCI in the extent and pattern of tissue
damage and inflammation [33], it is possible that T cell infiltration
is simply low in this model. Alternatively, peak lymphocyte
infiltration may occur at a different timepoint not examined here.
Some differentially expressed genes from the microarray were
related to the adaptive immune system and it should be noted that
even low numbers of T cells in the lesion site may have an impact
on the inflammatory response.
Macrophage Infiltration and Microglial Activation
The number of macrophages/activated microglia, likely the
most numerous immune cell type present in the acute phase of
inflammation, was not attenuated in injured EphA4 knockout
spinal cords. Altering macrophage properties without significantly
decreasing their number may improve outcomes following CNS
injury, as recently demonstrated in Mapkapk2 knockout mice [34].
However, it is currently unclear what contribution, if any, the
lower number of Arginase 1-positive macrophages is making to the
axonal outgrowth observed in EphA4 knockout mice. Arginase 1 is
highly expressed in a ‘‘pro-regenerative’’ subset of macrophages
[35,36,37], known as alternatively activated macrophages, in
response to parasitic infection via the STAT6 pathway. However it
has recently been shown that they can also be detrimental [38],
which may indicate tissue-specific variability in effects. The
expression of other common alternatively activated macrophage
markers, Chitinase 3-like 3 (Ym1), mannose receptor (CD206) and
Found in inflammatory zone 1 (Fizz1), were not significantly
different between injured genotypes in our data. Similarly the
microarray data did not provide evidence for a differential
expression of inducible nitric oxide synthase, interleukin (IL)-4,
IL-13 or the receptor IL4Ra, suggesting that other alternatively
activated macrophage properties are not altered. Arginase 1 is also
induced in classically activated (M1) macrophages in a STAT6
from the injury epicentre up to 500 mm rostrally and caudally (the example in B shows the injured left hand side of the spinal cord in A at higher
power). Injured wild-type and EphA4 knockout spinal cords were analysed at 2 (D, E), 4 (G, H) and 14 (J, K) days post-injury (arrowheads indicate the
injury epicentre). There was no significant difference between genotypes in the proportional CD11b+ area of any 100 mm rostro-caudal zone at 2 (F),
4 (I) or 14 (L) days post-injury. or within the total 1 mm rostro-caudal area in control spinal cords (C). Results show mean 6 SEM of n=3 wild-type and
n=2 EphA4 knockout controls; n=3 per genotype at 2 and 4 days post-injury and n=2 per genotype at 14 days. Scale bars: A=500 mm; D, E, G, H, J,
K=200 mm. WT=wild-type, KO=knockout, d.p.i.=days post-injury.
doi:10.1371/journal.pone.0037635.g003
Figure 4. The density of macrophages/activated microglia in the lesion epicentre does not differ between injured wild-type and
EphA4 knockout spinal cords. Transverse sections of hemisectioned spinal cord were immunostained with CD11b to label infiltrating
macrophages and activated microglia. Examples from wild-type (A) and EphA4 knockout (B) spinal cords 4 days post-injury are shown; the square
surrounds the CD11b+ lesions on the left hand side of the spinal cord. There was no difference between genotypes in the proportional area of CD11b
immunoreactivity within the injury epicentre at 2, 4 or 14 days post-injury (D). Higher power images of CD11b+ staining (example in C) were used to
determine the density of cells within the injury epicentre; no difference was seen between injured wild-type or EphA4 knockout mice at 2, 4 or 14
days post-injury (E). Images in A and B show DAPI nuclear counterstain. Results show mean 6 SEM of n=3 per genotype at 2 and 14 d.p.i. and n=6
per genotype at 4 d.p.i. Scale bars: A, B=500 mm; C=50 mm. WT=wild-type, KO=knockout, d.p.i.=days post-injury.
doi:10.1371/journal.pone.0037635.g004
Expression Profiling of SCI in EphA4 Knockout
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37635Expression Profiling of SCI in EphA4 Knockout
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37635independent manner via the Toll–like receptor 2/MyD88
pathway following parasitic infection [39,40]. Our data also did
not identify any of the genes currently known to be involved in this
pathway as differentially expressed although Tlr6 expression was
lower in injured EphA4 KO compared to injured WT spinal
cords.
An Arginase 1 expressing macrophage population also express-
ing mannose receptor and Fizz1, characteristic of alternatively
activated macrophages, was identified from the Immunological
genome project website [41]. This population also expresses high
levels (relative to other macrophage cell types) of a number of
genes that we identified as having attenuated increased expression
in our model (Table S1 and Fig. S4) (Casp1, Tlr6, RAB32, member
of Ras oncogene family (Rab32), Baculoviral IAP repeat-contain-
ing 1f (Birc1f), Selenoprotein X 1 (Sepx1), Glucan (1,4-alpha-),
branching enzyme 1 (Gbe1), Transmembrane protein 38b
(Tmem38b), Nupr1, Paraoxonase 3 (Pon3), Cysltr1 and Cd244).
Expression of Arginase 1, Nupr1, CD244 and Fcgr1 at CNS injury
sites is also strongly correlated in a murine cortical injury model
(GDS2850) (Fig. S5) and a murine SCI contusion model
(GDS2159) (Fig. S6 and S7), particularly at the early time points
of 1 and 3 days post-injury. Together with our results these data
support the hypothesis of an Arginase 1 expressing macrophage
population that is present at an early time point after CNS injury.
The pathway by which Arginase 1 is induced in macrophages
within injured CNS tissue and the function of Arginase 1 at the
injury site remains to be elucidated. However, previous studies
have demonstrated Arginase 1 expression in macrophages results
in lower levels of nitric oxide and subsequently reduced
inflammation [42,43].
Arginase 1-positive alternatively activated macrophages have
been shown to be less neurotoxic and more pro-regenerative than
classically activated macrophages in vitro [32] and it remains to be
determined whether a lower proportion of alternatively activated
macrophages could have any positive effects post-SCI. While the
wound-healing properties of alternatively activated macrophages
have been extensively characterised in vitro and in non-CNS tissue,
this may not translate directly to the injured spinal cord. For
example, one beneficial function of alternatively activated
macrophages is collagen deposition [44] which may not promote
regeneration in the injured CNS if the amount of fibrotic tissue is
increased. Additionally, the ‘edge’ and ‘inner’ Arginase 1-positive
macrophages may be contributing differently to the lesion
environment. There was no difference between genotypes in the
proportion of strongly Arginase 1-positive macrophages in ‘edge’
areas, which had the appearance of foamy macrophages and were
likely to be phagocytosing tissue and myelin debris. Additionally, it
is not certain that the relative proportion of activated microglia
and haematogenous macrophages are equivalent in the lesions of
wild-type and EphA4 knockout spinal cords, as immunohisto-
chemistry could not discriminate between these cells. Determining
this may be important as it has been suggested that ‘microglia-
dominant inflammation’, with less involvement of macrophages,
leads to better outcomes following SCI [45].
Alterations in Macrophages/Microglia Versus
Environmental Regulation of Phenotype
It is not clear whether the altered Arginase 1 expression is due to
heterogeneity in the macrophages themselves or rather is
indicative of altered factors in the lesion environment. It is
possible that the altered expression of Arginase 1 in EphA4
knockout macrophages is indicative of other neuroinflammatory
changes, whether or not it directly contributes to the axonal
outgrowth observed. Macrophage phenotype is sensitive to factors
in the surrounding environment and Arginase 1 expression
differences may indicate altered levels of inflammatory cytokines
in the lesion site, which peak soon after injury [46]. However,
unlike the intact spinal cord, factors in the lesion environment do
not appear to support an alternatively activated macrophage
phenotype [32].
The altered proportion of Arginase 1-positive macrophages may
be indicative of increased heterogeneity in the macrophage
population. The juxtaposition of Arginase 1-positive and negative
macrophages in densely populated regions of the lesion core,
which are presumably exposed to similar factors in the environ-
ment, suggests that cues within the lesion may not account for all
differences seen in macrophage phenotype. Factors which
contribute to immune cell heterogeneity are still being elucidated
[47]. Interpretation of the role of Arginase 1 expressing
macrophages following CNS injury in our model is complicated
by the fact that, while EphA4 has not been associated with myeloid
or monocyte development, EphA4 protein has been localised to
macrophages in human lung [48] and multiple sclerosis lesions
[19] and other Eph receptors and ephrin ligands are expressed in
monocytes and macrophages [10,19]. EphA4 is also expressed in
the murine Arginase 1 expressing macrophage population from
the Immunological database described above [41] (Fig. S4).This
raises the possibility that interaction of ephrin-expressing macro-
phages with EphA4-expressing astrocytes within the lesion
environment [6,8,22] may regulate macrophage properties.
Conclusions
Neuroinflammation is an important component of secondary
injury and repair following SCI. While the microarray data
indicates that a number of inflammation-related genes are
differentially expressed in the injured spinal cord of EphA4
knockout mice, elucidating the contribution of these differences to
regeneration may be challenging, especially if the cellular effects
are subtle. Nonetheless, our results indicate that in addition to
directly regulating axonal regeneration [6,8] or astrocyte respon-
Figure 5. The proportion of Arginase 1-positive macrophages/activated microglia is lower in EphA4 knockout compared to wild-
type spinal cords at 4 days post-injury. Transverse sections of hemisectioned spinal cord were double-labelled with Arginase 1 and CD11b to
identify the subset of infiltrating macrophages/activated microglia with Arginase 1 immunoreactivity. A representative example from a wild-type
spinal cord at 4 days post injury is shown in A, with positive staining on the injured left hand side. Cells with a foamy macrophage appearance located
in areas of tissue necrosis (ii, coded ‘edge’ areas) were more likely to be strongly Arginase 1-immunoreactive than densely packed macrophages not
surrounded by obvious areas of necrosis (i, coded ‘inner’ areas). There was a significantly lower proportion (*p=0.0018, B) of Arginase 1-positive
CD11b positive macrophages/activated microglia in densely packed ‘inner’ areas in EphA4 knockout (F-H) compared to wild-type (C-E) spinal cord
lesions at 4 days but no difference in the proportion (B) of Arginase 1-positive macrophages/activated microglia in necrotic ‘edge’ areas in EphA4
knockout (L-N) and wild-type (I-K) lesions. There was no difference between genotypes in the proportion of Arginase 1-positive macrophages/
activated microglia at 2 or 14 days post-injury (B), by which time the proportion of Arginase 1-positive macrophages/activated microglia had dropped
dramatically. Merged images include DAPI nuclear counterstain. Results show mean 6 SEM of n=6 per genotype at 4 days and n=3 per genotype at
2 days and 14 days post-injury Scale bars: A=500 mm; C-E, F-H, I-K, L-N=50 mm. ARG1=Arginase 1, WT=wild-type, KO=knockout, d.p.i.=days post-
injury.
doi:10.1371/journal.pone.0037635.g005
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contribute to repair of neural injury.
Supporting Information
Figure S1 Quality control of RNA and microarray
samples. A: A list of RNA samples used in the microarray and
their RIN as indicated by Bioanalyser assessment. RNA samples
had an RIN between 9 and 9.8 (out of 10) indicating all samples
were of high quality. B: A 3 dimensional PCA plot mapping
microarray samples based on their variation in genome-wide gene
expression. Samples with similar profiles cluster closer together. As
indicated by clustering of sham-operated samples of both
genotypes (in blue) and SCI samples of both genotypes (in red),
the largest variation was due to treatment and there were no
biological or technical outliers. WT=wild-type; KO=knockout.
(TIF)
Figure S2 Hierarchical clustering of differentially ex-
pressed genes generated by comparison of injured wild-
type and EphA4 knockout samples (all genes labelled).
Hierarchical clustering identified subsets of differentially expressed
genes with simr expression profiles across groups. KO=knockout.
(PDF)
Figure S3 Histology of wild-type and EphA4 knockout
spinal cords at multiple timepoints post-injury. Trans-
versely cryosectioned lumbar spinal cords from hemisectioned
wild-type mice are shown at 2 (A), 4 (B), and 14 (C) days post-
injury; the square surrounds the injured left hand side.
Horizontally sectioned spinal cords from hemisectioned wild-type
mice are shown at 2 (D), 4 (E), and 14 (F) days post-injury and
EphA4 knockout spinal cords at the same post-injury timepoints
are shown below (G-I). Full sections of spinal cord are shown in D
and G while the left hand side is shown in E, F, H and I.
Arrowheads indicate the injury site in D - I. Sections are stained
with haematoxylin and eosin. Scale bars: A-C, D, G=500 mm; E,
F, H, I=200 mm. d.p.i.=days post-injury.
(TIF)
Figure S4 Gene expression profiles of selected genes of
interest in murine immune cells obtained from Immu-
nological genome database. EphA4 is expressed in a small
number of macrophage populations (A). One population,
MF.Thio5.II-480hi.PC, co-expresses Cd11b (B) and also Arginase
1 (C) to a high level. This cell type also expresses Nupr1 (D), Fcgr1
(E) and Cd244 (F).
(DOCX)
Figure S5 Expression of Arg1, Nupr1, and Fcgr1 have
similar expression patterns in a murine cortical injury
model. Expression profile of selected genes from the GEO
dataset: GDS2850– Brain trauma model: time course in Mus
musculus. Analysis of brain at various time points up to 72 hours
following lateral controlled cortical impact injury. Images are from
the GEO website. The top line above each image details the
experiment number and probe set number corresponding to the
gene of interest. Along the Y axis is the relative gene expression
level and along the X axis is the different tissue samples and time
points included in the experiments. Note that the Y axis is a sliding
scale that varies between each gene to allow subtle differences in
values to be easily visualised, thus it is not appropriate to compare
expression values between genes. Genes of interest presented are:
EphA4 (A), Arginase 1 (Arg1, B), Nupr1 (C) Fcgr1 (D) and Cd244 (E).
(DOCX)
Figure S6 Expression of Arg1, Nupr1, CD244 and Fcgr1
have similar expression patterns in a murine spinal
cord injury model. Expression profiles of selected genes from
the GEO dataset: GDS2159– Spinal cord injury model: time
course, Mus musculus. Analysis of the T8 spinal cord segment up to
28 days after moderate contusion injury. Gene expression at the
site of impact compared to that at the adjacent rostral and caudal
regions. Images are captured from the GEO website. The top line
above each image details the experiment number and probe set
number corresponding to the gene of interest. Along the Y axis is
the relative gene expression level and along the X axis is the
different tissue samples and time points included in the
experiments. Note that the Y axis is a sliding scale that varies
between each genes to allow subtle differences in values to be
easily visualised, thus it is not appropriate to compare expression
values between genes. Genes of interest presented are: EphA4 (A),
Arginase 1 (Arg1, B), Nupr1 (C), Fcgr1 (D), CD244 (E), Ctla2a (F), Sla
(G), Casp1 (H), Cflar (I), Mapkapk2 (J), Tlr6 (K).
(DOCX)
Figure S7 Correlation between gene expression of Arg1,
Nupr1, Fcgr1 and Cd244 in CNS injury models over time.
Correlation plots for selected genes of interest showing positive
expression correlations in both SCI and cortical CNS injury
models (GDS2159 and GDS2850 respectively; see Fig S5 and S6)
across multiple time points. Displayed are naı ¨ve control (blue
points), sham injury control (green points) and injury samples (red
points). The numbers within the data points indicates the injury
time point in either hours (0.5 h, 4 h, 8 h) or days (1, 3, 7, 28)
following injury. Positive correlation plots are shown for Arg1 and
Nupr1 in SCI (Ai) and cortical injury (Aii); Arg1 and Fcgr1 in SCI
(Bi) and cortical injury (Bii); Arg1 and CD244 in SCI (Ci) and
cortical injury (Cii); and Nupr1 and Fcgr1 in SCI (Di) and cortical
injury (Dii).
(DOCX)
Table S1 Genes differentially expressed in injured wild-
type and EphA4 knockout spinal cord samples. Genes
differentially expressed between genotypes following CNS injury,
determined by a one-way ANOVA comparing injured groups
only. Genes were considered differentially expressed between
genotypes when p,0.01 and they had a fold change of $1.2.
Genes are ordered as in Figure S2.
(DOC)
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